Profile: Aeris Therapeutics deals with the development and commercialization of therapies for patients with emphysema and other advanced lung diseases. Our AeriSeal™ system is used for lung volume reduction. It is designed to provide a minimally invasive treatment alternative for patients with advanced emphysema who currently have limited treatment options.
FDA Registration Number: 3003882569
3 Products/Services (Click for related suppliers)
|• ENT Drug Applicator (FDA Code: LRD / 874.5220)|
|• Lung Volume Reduction Systems|
|• Lung-volume Testing Equipment|